Document is current
Any future updates will be listed below
-
Authors
Zhu, Yiren
Chen, Pinhua
Zhang, Zhengchao
He, XueYi
Wang, Ruoli
Fang, Qi
Xu, Zhixian
He, Wubing https://orcid.org/0009-0002-5187-6339
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Fujian Province (2024J011027)
Science and Technology Innovation Joint Fund Project of Fujian Province (2023Y9323)
Medical Innovation Project of Fujian Province (2020CXA007)
- License Information
-
More Information
Article History
Received: 4 December 2024
Accepted: 17 February 2025
First Online: 25 February 2025
Declarations
:
: All animal experiments were rigorously reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of Fujian Provincial Hospital, Fujian, China. The research encompassed two distinct projects: the first investigating the “Biological Effects and Mechanisms of aFGF Gene-modified Adipose-Derived Stem Cells (ADSCs) in the Treatment of Refractory Diabetic Wounds” (approval number IACUC-FPH-SL-20240321, granted on March 21, 2024), and the second exploring the “Role and Mechanism of Pak2 Protein in MAPK Signaling Pathway during BMP-2 and TGF-β3 Synergistic Promotion of Osteogenic Differentiation in Bone Marrow Stromal Cells” (approval number IACUC-FPH-SL-20240403[0232], granted on April 3, 2024). The Fujian Academy of Medical Sciences held a valid Experimental Animal Use License (SYXK 2016-0004) during the conduct of these studies.
: All co-authors have seen and agree with the contents of the manuscript for publication.
: No conflicts of interest, financial or otherwise, are declared by the authors.
